SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-045315
Filing Date
2024-05-20
Accepted
2024-05-20 17:40:40
Documents
1
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-65981.html 4  
1 PRIMARY DOCUMENT marketforms-65981.xml 4 6445
  Complete submission text file 0001213900-24-045315.txt   8329
Mailing Address 2000 CENTRAL AVENUE SUITE 100 BOULDER CO 80301
Business Address 2000 CENTRAL AVENUE SUITE 100 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111
Business Address 250 EAST 200 SOUTH, FLOOR 16 SALT LAKE CITY UT 84111 (212) 220-4444
Exploration Capital, LLC (Reporting) CIK: 0002003514 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 24966082